Eden Health GLP-1 vs Willow: Which GLP-1 Provider Is Better?
Short answer: Willow scores higher on our rubric, 7.5/10 against 6.9/10. Full reasoning, pricing and the cases where the other one wins are below.
Willow beats Eden Health GLP-1 overall, scoring 7.5/10 vs 6.9/10. Published pricing is not a like-for-like monthly comparison: Eden Health GLP-1 is from $249/mo; Willow is from $299/mo. Choose Eden Health GLP-1 for people with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their glp-1, with blood panels included. Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.
A side-by-side look at Eden Health GLP-1 and Willow to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Eden Health GLP-1
#42 of 54Premium online weight-loss program from Eden Health (San Francisco, founded 2021). Different from competitors in one specific way: every patient is paired with a board-certified obesity medicine doctor (a doctor with specialized training in weight and metabolism), not a general practitioner or nurse. Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly cost. Eden prescribes both compounded GLP-1s (custom-made versions, not the FDA-approved brand) and brand-name Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Eden Health GLP-1Willow
#20 of 54Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit Willow| Feature | Eden Health GLP-1 | Willow |
|---|---|---|
| Why each one | The only telehealth GLP-1 platform staffed by board-certified obesity medicine doctors (specialists in weight and metabolism), with quarterly lab panels included, the closest thing to in-person bariatric care delivered by mail. | One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category. |
| Our Score | 6.9/10 | 7.5/10 |
| Headline Price | from $249/mo | from $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | People with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their GLP-1, with blood panels included. | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes |
| Watch out for | $249/mo ongoing (month-to-month) is on the high end. Henry Meds is $199/mo for similar compounded care without labs; MEDVi is $179 for month one, then $299 for refills. | Compounded-only, no brand-name Wegovy or Zepbound through the platform |
| Ranking | #42 | #20 |
| Get started | Visit Eden Health GLP-1 | Visit Willow |
Pros & Cons Compared
Eden Health GLP-1
Pros
- +4.5 stars across 3,777 verified Trustpilot reviews, 77% give 5 stars. Replies to 99% of negative reviews. The strongest customer-experience signal of any provider in our table.
- +Doctors are board-certified obesity medicine specialists, not general practitioners. Specialized training in weight and metabolism.
- +Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly price. Most competitors don't include labs.
- +Mandatory check-in with the doctor before each dose increase. Won't rush you up the ladder.
- +Full medication choice: compounded semaglutide/tirzepatide AND brand-name Wegovy, Zepbound, Ozempic, Mounjaro.
Cons
- −$249/mo ongoing (month-to-month) is on the high end. Henry Meds is $199/mo for similar compounded care without labs; MEDVi is $179 for month one, then $299 for refills.
- −Cash-pay only, no insurance billing.
- −Cancellation friction is the main 1-star Trustpilot complaint (13% of reviews). Some users report being billed or shipped after they canceled.
- −Their website is not always user-friendly, multiple Trustpilot users mention they had to contact support to make payment or account changes.
- −Pharmacy partner not named specifically, 'state-licensed compounding pharmacies' in their marketing, but no individual facility named.
- −FDA warning letter #728279, issued June 8, 2026, cites false or misleading marketing claims about compounded GLP-1 products. It is a marketing/misbranding record, not an allegation that medication was unsafe.
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only, no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
- −Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024, less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Eden Health GLP-1 with a score of 7.5/10 vs 6.9/10. Published pricing is not a like-for-like monthly comparison: Eden Health GLP-1 is from $249/mo; Willow is from $299/mo. Eden Health GLP-1 offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Eden Health GLP-1 and Willow.
- Eden Health GLP-1 vs Tonik Wellnessfrom $149/mo
- Eden Health GLP-1 vs Novifrom $133/mo
- Eden Health GLP-1 vs LivBodyfrom $179/mo
- Willow vs Tonik Wellnessfrom $149/mo
- Willow vs Novifrom $133/mo
- Willow vs MangoRxfrom $299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Willow · 7.5/10